A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs tumor

Clinical Orthopaedics and Related Research

Volumn 471, Issue 3, 2013, Pages 834-842

  Eward, William C ^a   Mito, Jeffrey K ^a   Eward, Cindy A ^b   Carter, Jessica E ^a   Ferrer, Jorge M ^c   Kirsch, David G ^a   Brigman, Brian E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Veterinary Specialty Hospital of the Carolinas   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; FLUORESCENT DYE; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; DEVICES; DOG; FEMALE; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; IMAGING SYSTEM; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; SOFT TISSUE SARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG DISEASE; ENZYMOLOGY; FLUORESCENCE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MINIMAL RESIDUAL DISEASE; SARCOMA; SOFT TISSUE TUMOR; TIME; TUMOR RECURRENCE; VASCULARIZATION;

ANIMALS; CATHEPSINS; DOG DISEASES; DOGS; FEMALE; FLUORESCENCE; FLUORESCENT DYES; INJECTIONS, INTRAVENOUS; MALE; MOLECULAR IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; SARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS;

MLCS; MLOWN;

EID: 84875801897     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2560-8     Document Type: Conference Paper

References (19)

1. Allweis TM, Kaufman Z, Lelcuk S, Pappo I, Karni T, Schneebaum S, Spector R, Schindel A, Hershko D, Zilberman M, Sayfan J, Berlin Y, Hadary A, Olsha O, Paran H, Gutman M, Carmon M. A prospective, randomized, controlled, multicenter study of a real-time, intraoperative probe for positive margin detection in breast-conserving surgery. Am J Surg. 2008;196:483-489.
2. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet. 2010;42:715-721.
3. Briggs J, Paolini M, Chen QR, Wen X, Khan J, Khanna C. A compendium of canine normal tissue gene expression. PLoS One. 2011;6:e17107.
4. Brinkhof B, Spee B, Rothuizen J, Penning LC. Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem. 2006;356:36-43.
5. Ehrhart N. Soft-tissue sarcomas in dogs: a review. J Am Anim Hosp Assoc. 2005;41:241-246.
6. Haid A, Knauer M, Dunzinger S, Jasarevic Z, Köberle-Wührer R, Schuster A, Toeppker M, Haid B, Wenzl E, Offner F. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann Surg Oncol. 2007;14:3090-3101.
7. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-127.
8. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, Hornicek FJ, Weissleder R, Jacks T. A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med. 2007;13:992-997.
9. Kuntz CA, Dernell WS, Powers BE, Devitt C, Straw RC, Withrow SJ. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). J Am Vet Med Assoc. 1997;211:1147-1151.
10. Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg. 1999;134:190-194.
11. Mahoney JA, Fisher JC, Snyder SA, Hauck ML. Feasibility of using gene expression analysis to study canine soft tissue sarcomas. Mamm Genome. 2010;21:577-582.
12. Mito JK, Ferrer JM, Brigman BE, Lee CL, Dodd RD, Eward WC, Marshall LF, Cuneo KC, Carter JE, Ramasunder S, Kim Y, Lee WD, Griffith LG, Bawendi MG, Kirsch DG. Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer. 2012. doi: 10.1002/cncr.27458.
13. Mito JK, Riedel RF, Dodd L, Lahat G, Lazar AJ, Dodd RD, Stangenberg L, Eward WC, Hornicek FJ, Yoon SS, Brigman BE, Jacks T, Lev D, Mukherjee S, Kirsch DG. Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One. 2009;4:e8075.
14. Olson TP, Harter J, Munoz A, Mahvi DM, Breslin T. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol. 2007;14:2953-2960.
15. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996;14:859-868.
16. Reich M, Liefield T, Gould J, Lerner J, Tamavo P, Mesirov JP. GenePattern 2.0. Nat Genet. 2006;38:500-501.
17. Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L, Feng F, Biermann JS, Chugh R, Ray M, Ben-Josef E. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol. 2012;35:151-157.
18. Sadoski C, Suit HD, Rosenberg A, Mankin H, Efird J. Preoperative radiation, surgical margins, and local control of extremity sarcomas of soft tissues. J Surg Oncol. 1993;52:223-230.
19. Welle MM, Bleyt CR, Howard J, Rufenacht S. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology, and treatment. Vet Dermatol. 2008;19:321-339.